
Atrion Corporation ATRI
Quartalsbericht 2024-Q2
hinzugefügt 16.05.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBALSPB |
Anteile |
1.76 M |
Marktkapitalisierung |
$ 810 M |
EBITDA (LTM) |
$ 45.4 M |
P/E (LTM) |
- |
P/S (LTM) |
4.45 |
EPS (LTM) |
7.22 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
ICU Medical
ICUI
|
$ 129.31 | 4.57 % | $ 3.19 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 449.03 | 1.69 % | $ 160 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 61.75 | 0.49 % | $ 12.3 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Repro Med Systems
KRMD
|
$ 4.0 | 1.01 % | $ 185 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 67.28 | 1.51 % | $ 40.4 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 101.43 | 0.1 % | $ 2.3 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.79 | -0.01 % | $ 9.53 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 117.0 | 2.78 % | $ 3.74 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.4 | 14.99 % | $ 32.8 M | NYSE American | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 6.13 | 3.81 % | $ 52 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.77 | 3.12 % | $ 3.99 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 59.56 | 4.77 % | $ 3 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 215.97 | 0.72 % | $ 21.3 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 143.82 | 2.8 % | $ 6.97 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 64.17 | 0.27 % | $ 208 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 33.05 | 1.38 % | $ 1.64 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 10.16 | 5.07 % | $ 210 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.74 | 0.58 % | $ 79.7 M | Nasdaq Global Select Market | ||
|
Teleflex Incorporated
TFX
|
$ 135.18 | 1.84 % | $ 6.03 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 64.49 | 1.13 % | $ 3.82 B | Nasdaq Global Select Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.84 | 1.03 % | $ 1.96 B | Nasdaq Global Select Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 305.5 | 0.52 % | $ 22.1 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 26.09 | 4.57 % | $ 1.76 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.66 | -2.35 % | $ 19.8 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 63.47 | 4.43 % | $ 209 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 24.0 | 4.12 % | $ 1.15 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.85 | 6.94 % | $ 168 M | NYSE American | ||
|
Baxter International
BAX
|
$ 18.77 | 2.4 % | $ 9.63 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 209.86 | 1.0 % | $ 30.7 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.0 | 0.69 % | $ 1.38 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.4 | 7.78 % | $ 240 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.81 | 3.23 % | $ 482 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 146.95 | - | $ 42.3 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.57 | -1.79 % | $ 37.9 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.07 | -0.32 % | $ 226 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 111.74 | 2.97 % | $ 6.28 M | Nasdaq Global Select Market,SPB |